Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Aulos Bioscience, Inc.
Aulos Bioscience, Inc.
Essen Biotech
Second Life Therapeutics
Ocellaris Pharma, Inc.
University of Arizona
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Cancer Research UK
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Pfizer
Klus Pharma Inc.
Revolution Medicines, Inc.
4D pharma plc
Ludwig Institute for Cancer Research
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Celldex Therapeutics